Agenda Registration Join SOHO About SOHO
Agenda Registration Join SOHO About SOHO
LLS Logo SOHO Logo
Joint Meeting 2026

LLS & SOHO JOINT MEETING 2026 CONTROVERSIES IN
HEMATOLOGICAL MALIGNANCIES

17, 20, 24,28 Jun 2026
Online, Zoom Event
REGISTER NOW
CME
ACCREDITED

Welcome Note

We are pleased to welcome you to the LLSK & SOHO Joint Meeting 2026 – Controversies in Hematological Malignancies, to be held on Wed 17 Jun 2026 until Sun 28 Jun 2026 , at the Online – Zoom Event.

This joint scientific meeting, organized in collaboration between the Leukemia & Lymphoma Society (LLS) and the Society of Hematologic Oncology (SOHO), focuses on key controversies in the management of hematological malignancies.

Leading regional and international experts will discuss areas where clinical evidence, guidelines, and real-world practice may differ.

The program follows a debate-driven format and covers major disease areas including chronic leukemias, plasma cell dyscrasias, lymphoma, and acute leukemias.

Sessions will address important treatment decisions, emerging therapies, transplant considerations, and the care of elderly and high-risk patients.

We look forward to welcoming you to Kuwait for a valuable scientific exchange and an engaging educational experience.

Dr. Ahmad Alhuraiji
Dr. Ahmad Alhuraiji
Chairperson

Agenda

Explore the full schedule of sessions, discussions, and expert talks.

Session 1: Chronic leukemia
Moderator: Dr. Ahmad Alhuraiji - Dr. Mariam Alasfour

07:00 - 07:20 PM

FD vs Continuous therapy in high risk CLL? Yes or no?

Dr. Nitin Jain
Dr. Mohd Yassin
07:20 - 07:40 PM

2GTKi vs STAMPi in frontline CML treatment

Dr. Naeem Chaudri
Dr. Iman Abou Dalle
07:40 - 08:00 PM

Should we cytoreduce pts with idiopathic erythrocytosis. Yes or no?

Dr. Ahmad Alabdulkarim
Prof. Salam AlKindi
08:00 - 08:10 PM

Q&A

08:10 - 08:30 PM

Satellite symposia

TBA

Session 2: Plasma Cell dyscasia
Moderator: Dr. Mohammad S. Ebraheem - Dr. Bilal Alnouri

07:00 - 07:20 PM

Smoldering myeloma: to treat or not to treat?

Dr. Meletios Dimopoulos
Dr. Ramesh Pandita
07:20 - 07:40 PM

Fixed Duration vs MRD Adaptation: Rethinking Treatment Endpoints

Dr. Ashutosh wachelaker
Dr. Ghazi Alotaibi
07:40 - 08:00 PM

Choosing the Right Path in WM: BTKi or Chemoimmunotherapy?

Dr. Ibrahim Al Nabhani
Dr. Bilal Alnouri
08:00 - 08:10 PM

Q&A

08:10 - 08:30 PM

Satellite symposia

TBA

Session 3: Lymphoma
Moderator : Dr. Abdulaziz Hamadah - Dr. Rasha Abdultawab

07:00 - 07:20 PM

BrECADD or N-AVD in upfront HL. (BrECADD

Dr. Ali Bazarbachi
Dr. Abdulwahab Altoura
07:20 - 07:40 PM

Pola R-CHP or DA-EPOCH-R in DHL

Dr. Samar Ousia
Dr. Khaleel Alfaresi
07:40 - 07:50 PM

Q&A

07:50 - 08:10 PM

Satellite symposia

TBA

Session 4: Acute leukemia
Moderator : Dr. Fatima Khadadah - Dr. Yahya Almahmeed

07:00 - 07:20 PM

Is there a role for IC AML treatment in 2026, Yes or No?

Dr. Mansour Alfayez
Dr. Nicholas Short (USA)
07:20 - 07:40 PM

Ph+ B ALL: Is transplant needed in CR1? Yes or No

Dr. Saleem NGJ (KSA)
Dr. Iman Abou Dalle
07:40 - 08:00 PM

Should we drop chemotherapy for elderly with ALL?

Dr. Nitin Jain
Dr. Hind Salama
08:00 - 08:10 PM

Q&A

08:10 - 08:15 PM

Closing Remarks

Our Speakers

Meet the distinguished speakers joining us to share their expertise and insights at this event.

Dr. Nitin Jain
Dr. Nitin Jain
Dr. Mohd Yassin
Dr. Mohd Yassin
Dr. Naeem Chaudri
Dr. Naeem Chaudri
Dr. Iman Abou Dalle
Dr. Iman Abou Dalle
Dr. Ahmad Alabdulkarim
Dr. Ahmad Alabdulkarim
Prof. Salam AlKindi
Prof. Salam AlKindi
Dr. Meletios Dimopoulos
Dr. Meletios Dimopoulos
Dr. Ramesh Pandita
Dr. Ramesh Pandita
Dr. Ashutosh wachelaker
Dr. Ashutosh wachelaker
Dr. Ghazi Alotaibi
Dr. Ghazi Alotaibi
Dr. Ibrahim Al Nabhani
Dr. Ibrahim Al Nabhani
Dr. Bilal Alnouri
Dr. Bilal Alnouri
Dr. Ali Bazarbachi
Dr. Ali Bazarbachi
Dr. Abdulwahab Altoura
Dr. Abdulwahab Altoura
Dr. Samar Ousia
Dr. Samar Ousia
Dr. Khaleel Alfaresi
Dr. Khaleel Alfaresi
Dr. Mansour Alfayez
Dr. Mansour Alfayez
Dr. Nicholas Short (USA)
Dr. Nicholas Short (USA)
Dr. Saleem NGJ (KSA)
Dr. Saleem NGJ (KSA)
Dr. Hind Salama
Dr. Hind Salama

Scientific Committee

The Scientific Committee behind this event, ensuring academic quality, scientific rigor, and excellence in program development.

The Society of Hematologic Oncology (SOHO)

SOHO-Kuwait is part of the worldwide Society of Hematologic Oncology. In 2026, SOHO-Kuwait is honored to present a satellite meeting that extends SOHO’s educational mission to additional regions around the world.

  • Global professional society dedicated to clinicians, research scientists, and healthcare professionals specializing in hematologic cancers and related disorders.
  • Non-profit organization established in 2012 to advance worldwide research, education, prevention, clinical studies, and patient care in hematologic malignancies.
  • Mission-driven impact to accelerate international research and education by promoting the exchange of scientific information—founded and guided by world-renowned experts.
  • Education & networking through SOHO programs, meetings, and initiatives—connecting a worldwide community focused exclusively on hematologic oncology.
  • FREE membership — SOHO members gain access to worldwide educational resources and opportunities at no cost.
Membership is FREE. Join SOHO free of charge:
Join SOHO

Join SOHO

Become a member of the Society of Hematologic Oncology (SOHO) by joining FREE of charge at soho.click/join. As a member, you can join your local country chapter to receive updates on meetings and events in your region. Membership also provides access to SOHO Annual Meeting presentations, educational materials, and other exclusive member resources.

Free Membership Requirement
All ancillary SOHO meetings are required to offer FREE membership to all attendees through the main SOHO membership system:
sohoonline.org/SOHO/Membership/Join-SOHO • soho.click/join
Join Free Now View How to Join
Scan to Join
SOHO Join QR Code
Scan the QR code or visit: soho.click/join

Target Audience

This program is designed for healthcare professionals involved in the diagnosis and management of hematologic malignancies, including:

  • Consultant physicians in hematology, hematologic oncology, and medical oncology
  • Bone marrow and stem cell transplant specialists
  • Junior clinicians and fellows seeking advanced, debate-driven, case-based learning in hematologic malignancies
  • Medical residents with a strong interest in leukemia, lymphoma, and plasma cell disorders
  • Physicians and researchers involved in novel therapies, cellular therapy, and clinical trials
  • Specialized nursing staff and allied healthcare professionals involved in the care of patients with hematological malignancies
The program is structured to deliver high-level scientific updates, expert debate, and practical clinical insights, making it suitable for participants at different stages of training and clinical experience, from trainees to senior consultants.

Registration

Registration Deadline: 28/6/2026
After completing the registration, you will receive the Zoom access link by email.
Powered by Zoom • Your join link will be sent by email.

Frequently Asked Questions

  • Please ensure you use a valid private email address during registration.
  • All registration information must be accurate and up to date.
  • Multiple registrations under the same name or email are not allowed.
  • Onsite Attendance: Please present your confirmed ticket received via email to collect your conference badge at the registration desk.
  • Ensure all personal details are correct during registration to receive CME credits.
  • CME credits are granted upon verified attendance via QR check-in at the event.
  • Certificates will be sent post-event to your registered email.
  • Accepted payments: KNET, Visa, Mastercard, Diners, and AMEX.
  • Tickets are non-refundable once purchased.

WhatsApp us

© 2026 Organized & Managed By Quote Hub